Prescription required Serotonin 1A receptor agonist / 2A receptor antagonist

Buy Addyi (Flibanserin) — Online Prescription

Often called "female Viagra" or "the pink pill," Addyi (flibanserin) is a nightly prescription tablet for low sexual desire in women. Since December 2025 it is approved after menopause too. Here is how much it actually helps, the alcohol and drug-interaction rules, how it compares with Vyleesi, and how to avoid paying the $2,500+ list price.

Medically reviewed Medically reviewed by Darcey Melnyk, Pharmacist — NPI 1740713718 · Last updated 2026-11-12

Medical disclaimer This page is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting, stopping, or changing any medication. Never disregard professional medical advice or delay seeking it because of something you have read on this site.
Active ingredientFlibanserin
Dosage formTablet (100 mg)
Administration routeOral
WarningBoxed warning: Addyi with alcohol close in time raises the risk of severe low blood pressure and fainting. Wait at least 2 hours after 1 or 2 standard drinks before the bedtime dose, or skip that night's dose after 3 or more drinks. Addyi is contraindicated with moderate or strong CYP3A4 inhibitors (including fluconazole, ciprofloxacin, diltiazem, verapamil and grapefruit juice) and in liver impairment.
FDA Drug Facts — ADDYI

Indications: 1 INDICATIONS AND USAGE ADDYI is indicated for the treatment of women less than 65 years of age with acquired, generalized hypoactive sexual desire disorder (HSDD) as characterized by low sexual desire that causes marked distress or interpersonal difficulty and is not due to: • A co-existing medical or psychiatric condition, • Problems within the relationship, or • The effects of a medication or other drug substance. Acquired HSDD refers to HSDD that develops in a patient who previously had no p…

Boxed warning: WARNING: HYPOTENSION and SYNCOPE IN CERTAIN SETTINGS Interaction with Alcohol The use of ADDYI and alcohol together close in time increases the risk of severe hypotension and syncope [see Warnings and Precautions (5.1) ]. Counsel patients to wait at least two hours after consuming one or two standard alcoholic drinks before taking ADDYI at bedtime or to skip their ADDYI dose if they have consumed three or more standard alcoholic drinks that evening. Contraindicated with Strong or Moderate CYP3A4 Inhibitors The concomitant use of ADDYI and moderate or strong CYP3A4 inhibitors increases flibanse…

Contraindications: 4 CONTRAINDICATIONS ADDYI is contraindicated in patients: • Using concomitant moderate or strong CYP3A4 inhibitors [see Boxed Warning and Warnings and Precautions (5.2) ] . • With hepatic impairment [see Boxed Warning and Warnings and Precautions (5.5) ] . • With known hypersensitivity to ADDYI or any of its components. Reactions, including anaphylaxis, reactions consistent with angioedema (e.g., swelling of the face, lips, and mouth), pruritus, and urticaria have been reported [see Adverse Reac…

Excerpted from the FDA-approved prescribing information. Read the full label on Drugs@FDA →

openFDA label data — Updated 2026-11-20
Quick answer

Addyi (flibanserin) is the "pink pill": a prescription tablet taken every night at bedtime to treat low sexual desire that bothers you and has no other cause. Since December 2025 it is approved for women under 65 before or after menopause. It helps some women modestly, has strict alcohol and drug-interaction rules, and has no generic. The list price is over $2,500 a month, but a GoodRx coupon brings it to about $299, and we accept GoodRx.

Under 65Women before or after menopause, per the December 2025 label
43–48%Felt desire was much or very much improved on Addyi, vs. 31–38% on placebo
~$29930 tablets with a GoodRx coupon, vs. about $2,500+ retail (GoodRx, November 2026)

"Female Viagra": what's real and what isn't

Searches for "female Viagra," "the pink pill" or "sex pills for women" turn up four very different things. Only two of them are FDA-approved for women's sexual desire:

ProductWhat it isFDA status for womenHow it's used
Addyi (flibanserin)Daily tablet acting on serotonin receptors in the brainApproved for low desire (HSDD), women under 65, before or after menopause100 mg every night at bedtime
Vyleesi (bremelanotide)Self-injected melanocortin agonistApproved for HSDD, premenopausal women only1.75 mg injection at least 45 minutes before sex, as needed
Sildenafil or tadalafil (Viagra, Cialis)Erection drugs that increase blood flowNot approved for womenSometimes prescribed off-label; evidence in women is limited
OTC "arousal" pills, gummies, supplementsUnregulated supplementsNot evaluated by the FDAContents may not match the label

If you've seen sildenafil chews or "Viagra for women" sold online, know that neither sildenafil nor tadalafil is FDA-approved for women (see our sildenafil page). And the FDA has repeatedly found sexual-enhancement supplements containing hidden prescription drugs. If low desire is a real, persistent problem, an evaluated prescription is the safer route.

Who Addyi is for

The December 2025 label approves Addyi for women under 65 with acquired, generalized hypoactive sexual desire disorder (HSDD): low sexual desire that causes marked distress or relationship difficulty. Both words matter:

  • Acquired. Your desire used to be normal and dropped later. It isn't a lifelong pattern.
  • Generalized. It happens regardless of the partner, situation or type of stimulation.
  • No other cause. It isn't better explained by another medical or psychiatric condition, relationship problems, or a medication side effect. Antidepressants, hormonal birth control and other drugs can lower desire, so a medication review comes first.
  • Not for men. The label says so directly.
  • Not a performance enhancer. It isn't approved to improve arousal or orgasm on demand.
  • Not with liver disease, and not with moderate or strong CYP3A4 inhibitors (see interactions).
  • Not studied at 65 and older for approval purposes.

New since December 2025: the approval for postmenopausal women rests on a 24-week trial of 447 women under 65 (average age 55) who took Addyi. It was the first FDA-approved drug for low desire after menopause. Vyleesi is still approved only before menopause.

How well it works

Addyi doesn't create desire overnight, and the benefit is modest. These are the label's results after 24 weeks:

MeasureAddyiPlacebo
Extra satisfying sexual events per month (premenopausal, 3 trials)+1.6 to +2.5+0.8 to +1.5
Desire "much" or "very much" improved (premenopausal)43–48%31–38%
Sexual events "much" or "very much" improved (premenopausal)29–39%21–31%
At least "minimally" improved desire (premenopausal)43–51%31–39%
Extra satisfying events per month (postmenopausal, under 65)+0.9+0.6
Women who said desire was "much" or "very much" improvedRange across three 24-week trials in premenopausal women (Addyi label, section 14.1)
Addyi 100 mg
43–48%
Placebo
31–38%

Bar length uses the top of each range. The difference was 10 to 13 percentage points. Addyi also reduced how bothered women felt by low desire. Two of the three trials did not meet their daily-diary desire endpoint, which is part of why reviews of the drug are mixed.

Give it 8 weeks. The label says to stop Addyi if you notice no improvement by then, so it makes sense to fill a 30-day supply at first rather than 90 days.

The alcohol rule

This is the boxed warning. Alcohol close to an Addyi dose can drop blood pressure enough to cause fainting. The 2019 label change replaced a total ban with timing rules:

How much have you had to drink this evening?
None
Take Addyi at bedtimeAs usual.
1 or 2 drinks
Wait at least 2 hoursAfter your last drink, then take Addyi at bedtime.
3 or more
Skip tonight's doseTake the next one tomorrow at bedtime. Don't double up.
  • After the dose, no more alcohol until the next day.
  • One standard drink is a 12-ounce beer (5%), 5 ounces of wine (12%) or a 1.5-ounce shot (40%).
  • Bedtime only. Taking it during the day raises the risk of fainting, injuries and sleepiness. Don't drive or do anything that needs full alertness for at least 6 hours after a dose.
  • If you feel faint, lie down right away and get help if it doesn't pass.

Drug interactions to check first

Flibanserin is broken down by the liver enzyme CYP3A4. Drugs that block it raise flibanserin levels and can cause severe low blood pressure and fainting, so moderate and strong CYP3A4 inhibitors are contraindicated. Several are prescriptions women commonly get:

TypeExamples from the labelWhat to do
Strong CYP3A4 inhibitorsKetoconazole, itraconazole, posaconazole, clarithromycin, nefazodone, ritonavir and other HIV/hepatitis C protease inhibitors, conivaptanContraindicated
Moderate CYP3A4 inhibitorsFluconazole (Diflucan), ciprofloxacin, erythromycin, diltiazem, verapamil, atazanavir, grapefruit juiceContraindicated
Several weak CYP3A4 inhibitors togetherBirth control pills, cimetidine, fluoxetine, ginkgoDiscuss with your prescriber
Strong CYP2C19 inhibitorsSome PPIs, SSRIs, benzodiazepines, antifungalsMay raise levels; discuss
CYP3A4 inducersCarbamazepine, phenytoin, phenobarbital, rifampin, St. John's wortMake Addyi much less effective
  1. Need fluconazole or another inhibitor?Stop Addyi at least 2 days before the first dose of the inhibitor.
  2. Finished the inhibitor?Wait 2 weeks after its last dose before restarting Addyi.
  3. Not sure?Bring your full list, including supplements and grapefruit, and we'll check it before your first fill.

Side effects

Most side effects started within the first 14 days. From the label's tables:

Side effectPremenopausal: AddyiPlaceboPostmenopausal: AddyiPlacebo
Dizziness11.4%2.2%7.9%3.3%
Sleepiness11.2%2.9%7.7%1.8%
Nausea10.4%3.9%6.6%3.9%
Fatigue9.2%5.5%3.0%3.9%
Insomnia4.9%2.8%5.7%3.4%
Dry mouth2.4%1.0%2.4%1.3%
Stopped because of side effects13%6%9%5%

Fainting and severe low blood pressure are the serious risks, mostly with alcohol, interacting drugs, liver problems or daytime dosing. Allergic reactions, including swelling of the face and lips, have also been reported.

Addyi vs. Vyleesi

Nightly tablet

Addyi (flibanserin)

Who
Women under 65, before or after menopause
Schedule
100 mg every night at bedtime
Main limits
Alcohol timing; CYP3A4 drug interactions; no liver disease
Common side effects
Dizziness, sleepiness, nausea (about 1 in 10 each)
Generic
None
As-needed injection

Vyleesi (bremelanotide)

Who
Premenopausal women only
Schedule
1.75 mg autoinjector, at least 45 min before sex; max 1 dose per 24 h, 8 per month recommended
Main limits
Raises blood pressure briefly (up to 6/3 mmHg); not for high cardiovascular risk
Common side effects
Nausea in 40% (usually better by the second dose), flushing, headache; darkened skin patches in 1%
Generic
None

Neither is better for everyone. Addyi fits women who want a routine pill and can live with the alcohol rules. Vyleesi fits premenopausal women who'd rather dose only when they plan to have sex and drink socially, if they can tolerate nausea and an injection. Your prescriber can help weigh it.

Price, coupons and getting a prescription

  • There is no generic. Addyi is the only FDA-approved flibanserin in the US, so a website offering "generic flibanserin" is selling an unapproved product. See BeSafeRx for how to spot a fake pharmacy.
  • Don't pay list price. GoodRx shows about $2,500 to $2,870 retail for 30 tablets and about $299 with its coupon through a Sprout partnership. We accept GoodRx and SingleCare.
  • Commercial insurance? Most plans and Medicare don't cover Addyi, but Sprout offers a savings card for commercially insured patients. Ask us to run whichever is cheaper.
  • Any prescriber can write it. Prescriber and pharmacy certification ended in 2019. A gynecologist, primary care doctor or telehealth provider can e-prescribe it to us.
  • Start with 30 days. If you see no improvement by 8 weeks, the label says to stop.

Have a prescription or a question about interactions? Call us at (860) 522-9289.

FDA drug shortage status

No active shortage reported — No shortage records found for this generic name.

FDA openFDA — Updated 2026-11-20

Addyi (Flibanserin) Prices in the USA

These are estimated average US retail cash prices — not insurance copays, not coupon prices, and not a quote from Arrow Pharmacy. Actual cost varies significantly by pharmacy, region, quantity, and insurance. There is no generic flibanserin in the US: Addyi from Sprout Pharmaceuticals is the only FDA-approved product. With a GoodRx coupon (a partnership with Sprout), GoodRx lists about $299 for 30 tablets, and Arrow Pharmacy accepts GoodRx. Call us at (860) 522-9289 for a current price.

Dosage Brand-name avg. price
100 mg (30 tablets) $2,500–2,870
Average market pricing — Updated 2026-11-12

Frequently asked questions

Is Addyi really "female Viagra"?

Only as a nickname. Viagra (sildenafil) increases blood flow for an erection and is taken before sex. Addyi acts on serotonin receptors in the brain to treat low desire, and it is taken every night at bedtime, not before sex. It is not approved to enhance sexual performance, and it is not approved for men.

Can postmenopausal women take Addyi?

Yes, since December 2025. The FDA expanded the label from premenopausal women to women under 65 with acquired, generalized hypoactive sexual desire disorder (HSDD), before or after menopause. It is still not approved for women 65 and older. Vyleesi, the other HSDD drug, remains approved only before menopause.

Does Addyi actually work?

Modestly, for some women. In the three main trials in premenopausal women, satisfying sexual events rose by about 1.6 to 2.5 per month on Addyi versus 0.8 to 1.5 on placebo, and 43 to 48% of women on Addyi said their desire was much or very much improved, compared with 31 to 38% on placebo. The label says to stop after 8 weeks if you notice no improvement.

Is there a generic flibanserin?

No. Addyi (Sprout Pharmaceuticals, NDA 022526) is the only FDA-approved flibanserin product in the US, and there is no generic in the CMS NADAC pharmacy-cost survey. Websites selling "generic flibanserin" are selling an unapproved product.

How much does Addyi cost?

GoodRx lists the retail price for 30 tablets at about $2,500 to $2,870, and a GoodRx coupon price of about $299 through a partnership with Sprout. Most insurance and Medicare plans don't cover it, but Sprout also offers a savings card for commercially insured patients. Arrow Pharmacy accepts GoodRx; call us to check today's price.

Can I drink alcohol on Addyi?

With limits. Wait at least 2 hours after 1 or 2 standard drinks before taking your bedtime dose. If you have had 3 or more drinks that evening, skip that night's dose. After you take Addyi, don't drink again until the next day. One standard drink is a 12-ounce beer, 5 ounces of wine or a 1.5-ounce shot.

Can I take Addyi with fluconazole (Diflucan) or an antibiotic?

Not at the same time with some of them. Fluconazole, ciprofloxacin, erythromycin, clarithromycin, diltiazem, verapamil and grapefruit juice are moderate or strong CYP3A4 inhibitors, which are contraindicated with Addyi because they raise flibanserin levels and can cause fainting. Stop Addyi at least 2 days before starting one, and wait 2 weeks after the last dose before restarting Addyi. Ask your pharmacist before combining anything.

Can men take Addyi?

No. The label states Addyi is not indicated in men. For men, low desire is usually evaluated for low testosterone or other causes, and erection problems are treated with drugs like sildenafil or tadalafil.

Do I need a special certified doctor or pharmacy?

No. Certification of prescribers and pharmacies under the original Addyi safety program was dropped in 2019, when the FDA also replaced the total alcohol ban with the current timing rules. Any licensed prescriber, including a telehealth provider, can prescribe it, and Arrow Pharmacy can fill it.

Are over-the-counter female arousal pills the same thing?

No. No FDA-approved drug for female sexual desire is sold without a prescription. "Instant arousal" pills, gummies and supplements are not evaluated by the FDA for safety or effectiveness, and the FDA has repeatedly found sexual-enhancement supplements containing hidden prescription drugs.

Sources (7)

  1. Addyi (flibanserin) tablets: prescribing information, including boxed warning (revised December 2025) — DailyMed / U.S. National Library of Medicine
  2. Addyi label, NDA 022526 supplement 13 (postmenopausal indication) — U.S. Food and Drug Administration
  3. Vyleesi (bremelanotide) injection: prescribing information — DailyMed / U.S. National Library of Medicine
  4. FDA approves expanded use of flibanserin for HSDD in women (December 15, 2025) — Contemporary OB/GYN
  5. Sprout's Addyi loses blanket alcohol contraindication and REMS distribution restrictions (October 2019) — Pink Sheet
  6. Addyi prices and coupons (retail and coupon price, 100 mg x 30) — GoodRx (consumer price reference, checked November 2026)
  7. BeSafeRx: Know Your Online Pharmacy — U.S. FDA
Call (860) 522-9289 Refill online